Literature DB >> 19652143

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

K Marder1, H Zhao, S Eberly, C M Tanner, D Oakes, I Shoulson.   

Abstract

OBJECTIVE: To examine caloric intake, dietary composition, and body mass index (BMI) in participants in the Prospective Huntington At Risk Observational Study (PHAROS).
METHODS: Caloric intake and macronutrient composition were measured using the National Cancer Institute Food Frequency Questionnaire (FFQ) in 652 participants at risk for Huntington disease (HD) who did not meet clinical criteria for HD. Logistic regression was used to examine the relationship between macronutrients, BMI, caloric intake, and genetic status (CAG <37 vs CAG > or =37), adjusting for age, gender, and education. Linear regression was used to determine the relationship between caloric intake, BMI, and CAG repeat length.
RESULTS: A total of 435 participants with CAG <37 and 217 with CAG > or =37 completed the FFQ. Individuals in the CAG > or =37 group had a twofold odds of being represented in the second, third, or fourth quartile of caloric intake compared to the lowest quartile adjusted for age, gender, education, and BMI. This relationship was attenuated in the highest quartile when additionally adjusted for total motor score. In subjects with CAG > or =37, higher caloric intake, but not BMI, was associated with both higher CAG repeat length (adjusted regression coefficient = 0.26, p = 0.032) and 5-year probability of onset of HD (adjusted regression coefficient = 0.024; p = 0.013). Adjusted analyses showed no differences in macronutrient composition between groups.
CONCLUSIONS: Increased caloric intake may be necessary to maintain body mass index in clinically unaffected individuals with CAG repeat length > or =37. This may be related to increased energy expenditure due to subtle motor impairment or a hypermetabolic state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652143      PMCID: PMC2725927          DOI: 10.1212/WNL.0b013e3181b04aa2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Nutritional evaluation of Huntington disease patients.

Authors:  L M Morales; J Estévez; H Suárez; R Villalobos; L Chacín de Bonilla; E Bonilla
Journal:  Am J Clin Nutr       Date:  1989-07       Impact factor: 7.045

2.  Higher sedentary energy expenditure in patients with Huntington's disease.

Authors:  R E Pratley; A D Salbe; E Ravussin; J N Caviness
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

3.  Weight loss in early stage of Huntington's disease.

Authors:  L Djoussé; B Knowlton; L A Cupples; K Marder; I Shoulson; R H Myers
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

4.  Validation of a self-administered diet history questionnaire using multiple diet records.

Authors:  G Block; M Woods; A Potosky; C Clifford
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

5.  Weight loss in Parkinson's disease.

Authors:  Honglei Chen; Shumin M Zhang; Miguel A Hernán; Walter C Willett; Alberto Ascherio
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

6.  Weight loss in Huntington disease increases with higher CAG repeat number.

Authors:  N A Aziz; J M M van der Burg; G B Landwehrmeyer; P Brundin; T Stijnen; R A C Roos
Journal:  Neurology       Date:  2008-11-04       Impact factor: 9.910

7.  Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease.

Authors:  Shi-Hua Li; Zhao-Xue Yu; Cui-Lin Li; Huu-Phuc Nguyen; Yong-Xing Zhou; Chuxia Deng; Xiao-Jiang Li
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

8.  Assessment of the nutrition status of patients with Huntington's disease.

Authors:  Araceli Trejo; Rosa María Tarrats; Ma Elisa Alonso; Marie-Catherine Boll; Adriana Ochoa; Leora Velásquez
Journal:  Nutrition       Date:  2004-02       Impact factor: 4.008

9.  Rate and correlates of weight change in Huntington's disease.

Authors:  J M Hamilton; T Wolfson; G M Peavy; M W Jacobson; J Corey-Bloom
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  28 in total

1.  Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.

Authors:  Karen Marder; Yian Gu; Shirley Eberly; Caroline M Tanner; Nikolaos Scarmeas; David Oakes; Ira Shoulson
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

2.  Fat-free mass and its predictors in Huntington's disease.

Authors:  S D Süssmuth; V M Müller; C Geitner; G B Landwehrmeyer; S Iff; A Gemperli; Michael Orth
Journal:  J Neurol       Date:  2015-04-23       Impact factor: 4.849

3.  Measures of growth in children at risk for Huntington disease.

Authors:  Jessica K Lee; Kathy Mathews; Bradley Schlaggar; Joel Perlmutter; Jane S Paulsen; Eric Epping; Leon Burmeister; Peg Nopoulos
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

Review 4.  Diagnosis and treatment of chorea syndromes.

Authors:  Andreas Hermann; Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

5.  Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease.

Authors:  Caroline Tanner; Karen Marder; Shirley Eberly; Kevin Biglan; David Oakes; Ira Shoulson
Journal:  Mov Disord       Date:  2018-01-03       Impact factor: 10.338

6.  Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.

Authors:  Jonas Alex Morales Saute; Andrew Chaves Feitosa da Silva; Gabriele Nunes Souza; Aline Dutra Russo; Karina Carvalho Donis; Leonardo Vedolin; Maria Luiza Saraiva-Pereira; Luis Valmor Cruz Portela; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

7.  Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's disease.

Authors:  Ashish Kumar; Andrew Kneynsberg; Janusz Tucholski; Giselle Perry; Thomas van Groen; Peter J Detloff; Mathieu Lesort
Journal:  Exp Neurol       Date:  2012-06-12       Impact factor: 5.330

Review 8.  Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.

Authors:  Huan Cai; Wei-na Cong; Sunggoan Ji; Sarah Rothman; Stuart Maudsley; Bronwen Martin
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

9.  Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism.

Authors:  Jane Y Chen; Conny Tran; Lin Hwang; Gang Deng; Michael E Jung; Kym F Faull; Michael S Levine; Carlos Cepeda
Journal:  J Huntingtons Dis       Date:  2016

10.  Abnormal Weight and Body Mass Index in Children with Juvenile Huntington's Disease.

Authors:  Alexander Tereshchenko; Michael McHugh; Jessica K Lee; Pedro Gonzalez-Alegre; Kaitlin Crane; Jeffrey Dawson; Peg Nopoulos
Journal:  J Huntingtons Dis       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.